104
Participants
Start Date
March 31, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Dupilumab
Solution for injection, one subcutaneous injection.
Placebo (for Dupilumab)
Solution for injection, one subcutaneous injection.
Fluticasone/Salmeterol combination therapy
Oral inhalation twice daily.
Fluticasone monotherapy
Oral inhalation twice daily.
Albuterol
Oral inhalation as needed.
Levalbuterol
Oral inhalation as needed.
Investigational Site Number 840037, Pittsburgh
Investigational Site Number 840040, Hershey
Investigational Site Number 840009, Upland
Investigational Site Number 840014, Baltimore
Investigational Site Number 840049, Richmond
Investigational Site Number 840008, Papillion
Investigational Site Number 840027, Charleston
Investigational Site Number 840044, Tallahassee
Investigational Site Number 840029, Tampa
Investigational Site Number 840053, Owensboro
Investigational Site Number 840023, Sylvania
Investigational Site Number 840028, Indianapolis
Investigational Site Number 840038, Iowa City
Investigational Site Number 840034, Madison
Investigational Site Number 840003, Minneapolis
Investigational Site Number 840010, Minneapolis
Investigational Site Number 840022, Bozeman
Investigational Site Number 840006, St Louis
Investigational Site Number 840013, St Louis
Investigational Site Number 840021, Overland Park
Investigational Site Number 840025, Omaha
Investigational Site Number 840045, Oklahoma City
Investigational Site Number 840050, San Antonio
Investigational Site Number 840030, El Paso
Investigational Site Number 840011, Denver
Investigational Site Number 840017, Denver
Investigational Site Number 840031, Colorado Springs
Investigational Site Number 840032, Los Angeles
Investigational Site Number 840036, Los Angeles
Investigational Site Number 840035, Rolling Hills Estates
Investigational Site Number 840046, Long Beach
Investigational Site Number 840048, Riverside
Investigational Site Number 840005, Mission Viejo
Investigational Site Number 840047, Anaheim
Investigational Site Number 840007, Orange
Investigational Site Number 840041, San Francisco
Investigational Site Number 840042, San Francisco
Investigational Site Number 840039, San Jose
Investigational Site Number 840002, Stockton
Investigational Site Number 840024, Santa Rosa
Investigational Site Number 840001, Lake Oswego
Investigational Site Number 840016, Portland
Investigational Site Number 840012, Medford
Investigational Site Number 840020, Seattle
Investigational Site Number 840026, New Haven
Investigational Site Number 840015, North Dartmouth
Investigational Site Number 840018, Princeton
Investigational Site Number 840004, Winston-Salem
Investigational Site Number 840052, South Burlington
Investigational Site Number 840019, Tacoma
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY